Evaluating long-term outcomes of hip replacement surgeries
Official title: Multicentric Observational PMCF Study to Evaluate Long-term Outcome, Performance and Safety of Implantable Devices in Hip Arthroplasty
Run by Corin · NCT02230826 · Data updated 2026-11-12
This study is trying to see how well Corin hip replacement devices work and how safe they are for people getting hip surgery over the long term.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2500 (estimated) |
| Sponsor | Corin Industry-sponsored |
| Locations | 13 sites (Bordeaux and 12 other locations) |
| Status | Recruiting |
| Started | May 2014 |
| Main results expected | December 2034 |
| Study ends | December 2044 |
| Registry record updated | March 18, 2026 |
| Trial ID | NCT02230826 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who require hip arthroplasty surgery with Corin hip devices.
✕Probably not a fit
Patients with high surgical risks, existing tumors, or contraindications for arthroplasty with Corin devices may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect long-term safety and efficacy data on commercially available hip arthroplasty products, specifically focusing on Corin hip devices. It will gather outcome data for post-market surveillance and clinical evaluations, which will contribute to peer-reviewed publications regarding the performance and safety of these devices over time. Participants will include individuals who are undergoing hip arthroplasty surgery with the specified devices and have consented to participate in the study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness and safety of hip replacement surgeries using Corin devices.
How similar studies have gone: Other studies evaluating long-term outcomes of hip arthroplasty have shown success, indicating that this approach is supported by existing research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Man or woman \>18 years * Subjects with indication of arthroplasty surgery with Corin hip devices which are under assessment as part of this PMCF study * Subjects who agreed for study participation. Exclusion Criteria: * Subjects with existing tumour and/or particularly high surgical risk- * Subjects with anaesthetic risk class IV or higher * Subjects under guardianship and/or unable to follow procedures or matters related to the study (examples: Illiterate, recent psychotic or mania disorders and / or inability to comply with usual follow-up visits.) * Contraindications for arthroplasty with a Corin hip devices as per product IFU
Where it's running
-
Polyclinique Henin Beaumont
Hénin-Beaumont, France Recruiting -
CHU de Nice
Nice, France Recruiting -
Hôpital de la Croix Saint-Simon
Paris, France Recruiting -
Hôpital Provo
Roubaix, France Recruiting -
Polyclinique St Georges de Didonne
Saint-Georges-de-Didonne, France Recruiting -
Hôpital Jean Bernard
Valenciennes, France Recruiting
Show 7 more locations
-
CHU de Bordeaux - Groupe Hospitalier Pellegrin
Bordeaux, France Active not recruiting -
clinique Oxford Cannes
Cannes, France Terminated -
CH Dunkerque
Dunkirk, France Terminated -
Centre Hospitalier Régionnal d'Orléans - Site La Source
Orléans, France Terminated -
Clinique Arago
Paris, France Terminated -
Hopital privé Saint-Martin
Pessac, France Active not recruiting -
Médipôle Garonne
Toulouse, France Terminated
Study contacts
- Study coordinator: Vanessa Grimaud
- Email: vanessa.grimaud@coringroup.com
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Collarless Actis hip stem for cementless hip replacement in Asian patients
This study tests how well a collarless Actis hip stem works in adults undergoing primary hip replacement, focusing on outcomes over five years in an East Asian population.
-
Liposomal bupivacaine plus bupivacaine versus ropivacaine for PENG block in hip replacement
This trial will test whether adding liposomal bupivacaine to regular bupivacaine for a pericapsular nerve group (PENG) block gives longer and better pain relief than ropivacaine after hip replacement surgery.
-
Monitoring the performance of hip replacement devices
This study is testing how safe and effective new hip replacement devices are for patients getting hip surgery by tracking their progress before and after the operation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.